Testing effectiveness (Phase 2)Ended earlyNCT00958841
What this trial is testing
Study of Pasireotide in Patients With Rare Tumors of Neuroendocrine Origin
Who this might be right for
Pancreatic NeoplasmPituitary NeoplasmNelson Syndrome+1 more
Novartis Pharmaceuticals 118